Keywords: Newron, Safinamide, Meiji Seika, Asian territories, Parkinson's disease

Newron gets new partner for safinamide

Article | 06 January 2012

Print This

Italy-headquartered R&D firm Newron Pharmaceuticals (SIX: NWRN) yesterday revealed that it has agreed with Japan’s Meiji ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in